CN116059251A - 一种采用生物酶体外培植天然品质牛黄的方法 - Google Patents
一种采用生物酶体外培植天然品质牛黄的方法 Download PDFInfo
- Publication number
- CN116059251A CN116059251A CN202310206180.8A CN202310206180A CN116059251A CN 116059251 A CN116059251 A CN 116059251A CN 202310206180 A CN202310206180 A CN 202310206180A CN 116059251 A CN116059251 A CN 116059251A
- Authority
- CN
- China
- Prior art keywords
- biological enzyme
- bezoar
- biological
- natural
- mixed solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 108
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 108
- 206010004542 Bezoar Diseases 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000000338 in vitro Methods 0.000 title claims abstract description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 46
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 23
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 23
- 239000011718 vitamin C Substances 0.000 claims abstract description 23
- 102000004142 Trypsin Human genes 0.000 claims abstract description 22
- 108090000631 Trypsin Proteins 0.000 claims abstract description 22
- 239000012588 trypsin Substances 0.000 claims abstract description 22
- 210000000941 bile Anatomy 0.000 claims abstract description 12
- 241000588724 Escherichia coli Species 0.000 claims abstract description 11
- 241000222175 Diutina rugosa Species 0.000 claims abstract description 8
- 239000011259 mixed solution Substances 0.000 claims description 52
- 239000000243 solution Substances 0.000 claims description 42
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 9
- 108010080698 Peptones Proteins 0.000 claims description 9
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 9
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 9
- 235000019319 peptone Nutrition 0.000 claims description 9
- 238000005185 salting out Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 235000015278 beef Nutrition 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 241001134775 Lysinibacillus fusiformis Species 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000004227 calcium gluconate Substances 0.000 claims description 3
- 229960004494 calcium gluconate Drugs 0.000 claims description 3
- 235000013927 calcium gluconate Nutrition 0.000 claims description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 abstract description 30
- 241000193403 Clostridium Species 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 241001529742 Rosmarinus Species 0.000 abstract 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 14
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 10
- 241000283690 Bos taurus Species 0.000 description 10
- 239000004380 Cholic acid Substances 0.000 description 10
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 10
- 229960002471 cholic acid Drugs 0.000 description 10
- 235000019416 cholic acid Nutrition 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 7
- 239000013558 reference substance Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000012364 cultivation method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- ZMZINYUKVRMNTG-UHFFFAOYSA-N acetic acid;formic acid Chemical compound OC=O.CC(O)=O ZMZINYUKVRMNTG-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310206180.8A CN116059251B (zh) | 2023-03-07 | 2023-03-07 | 一种采用生物酶体外培植天然品质牛黄的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310206180.8A CN116059251B (zh) | 2023-03-07 | 2023-03-07 | 一种采用生物酶体外培植天然品质牛黄的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116059251A true CN116059251A (zh) | 2023-05-05 |
CN116059251B CN116059251B (zh) | 2023-06-16 |
Family
ID=86173332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310206180.8A Active CN116059251B (zh) | 2023-03-07 | 2023-03-07 | 一种采用生物酶体外培植天然品质牛黄的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116059251B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114703109A (zh) * | 2022-05-10 | 2022-07-05 | 山东中医药大学 | 一种耐受牛胆汁的牛黄转化菌筛选培养基、配制方法及应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1347700A (zh) * | 2001-10-12 | 2002-05-08 | 武汉大鹏药业有限公司 | 一种利用天然牛胆汁在动物牛体外培育药用牛胆结石的方法 |
CN101474209A (zh) * | 2009-01-23 | 2009-07-08 | 刘化侠 | 酶育牛黄的制备方法 |
CN103316046A (zh) * | 2013-06-09 | 2013-09-25 | 宁波优美肽生物科技有限公司 | 一种体外培育牛黄的酶促生产工艺 |
CN104774885A (zh) * | 2015-04-24 | 2015-07-15 | 武汉健民大鹏药业有限公司 | 一种利用发酵法从牛胆汁中提取胆红素的方法 |
CN109498656A (zh) * | 2018-11-02 | 2019-03-22 | 宁波市成大机械研究所 | 一种利用生物酶技术制备人工牛黄的方法 |
CN114533763A (zh) * | 2022-02-17 | 2022-05-27 | 肖德煊 | 一种新型体外培育牛黄电结石方法 |
US20230080878A1 (en) * | 2020-02-21 | 2023-03-16 | Jiangsu Kanion Pharmaceutical Co., Ltd. | Application of traditional chinese medicine composition in preparation of drugs for treating or preventing coronavirus infection |
-
2023
- 2023-03-07 CN CN202310206180.8A patent/CN116059251B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1347700A (zh) * | 2001-10-12 | 2002-05-08 | 武汉大鹏药业有限公司 | 一种利用天然牛胆汁在动物牛体外培育药用牛胆结石的方法 |
CN101474209A (zh) * | 2009-01-23 | 2009-07-08 | 刘化侠 | 酶育牛黄的制备方法 |
CN103316046A (zh) * | 2013-06-09 | 2013-09-25 | 宁波优美肽生物科技有限公司 | 一种体外培育牛黄的酶促生产工艺 |
CN104774885A (zh) * | 2015-04-24 | 2015-07-15 | 武汉健民大鹏药业有限公司 | 一种利用发酵法从牛胆汁中提取胆红素的方法 |
CN109498656A (zh) * | 2018-11-02 | 2019-03-22 | 宁波市成大机械研究所 | 一种利用生物酶技术制备人工牛黄的方法 |
US20230080878A1 (en) * | 2020-02-21 | 2023-03-16 | Jiangsu Kanion Pharmaceutical Co., Ltd. | Application of traditional chinese medicine composition in preparation of drugs for treating or preventing coronavirus infection |
CN114533763A (zh) * | 2022-02-17 | 2022-05-27 | 肖德煊 | 一种新型体外培育牛黄电结石方法 |
Non-Patent Citations (2)
Title |
---|
DONG XIANG ET AL.: "Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis", 《FRONTIERS IN PHARMACOLOGY》, vol. 10, pages 1 - 14 * |
修今生等: "不同大肠杆菌菌株的β-葡萄糖醛酸酶活性及对培植牛黄产量与胆红素含量的影响", 《福建农业大学学报》, vol. 24, no. 1, pages 75 - 78 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114703109A (zh) * | 2022-05-10 | 2022-07-05 | 山东中医药大学 | 一种耐受牛胆汁的牛黄转化菌筛选培养基、配制方法及应用 |
CN114703109B (zh) * | 2022-05-10 | 2023-09-01 | 山东中医药大学 | 一种耐受牛胆汁的牛黄转化菌筛选培养基、配制方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN116059251B (zh) | 2023-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5525622B2 (ja) | 糖尿病治療用複合微生物製剤及びその製造方法と利用 | |
CN116059251B (zh) | 一种采用生物酶体外培植天然品质牛黄的方法 | |
CN1171991C (zh) | 人神经干细胞的培养方法 | |
CN108403498B (zh) | 一种纳豆提取液的制备方法及其应用 | |
CN112430546B (zh) | 莱茵衣藻、莱茵衣藻粉的异养发酵制备方法及应用 | |
CN106913583A (zh) | 人间充质干细胞源外泌体生物活性制剂的制备方法及应用 | |
CN116570640B (zh) | 葵花盘生物碱及衍生物在降尿酸溶解痛风石产品中的应用 | |
CN110408568B (zh) | 一株高产蛋白酶的地衣芽孢杆菌及其发酵产酶方法 | |
CN113024680A (zh) | 一种具有显著益生活性羊栖菜多糖及其制备方法与应用 | |
CN116445346A (zh) | 一种改善多囊卵巢综合征的罗伊氏乳杆菌及其应用 | |
CN112280720A (zh) | 一株多形拟杆菌gl-02及其与胆汁酸复配的复合菌剂与应用 | |
CS235079B2 (en) | Method of antitumour substance preparation | |
CN116407572A (zh) | 一种沙棘提取物及其制备方法和应用 | |
CN102154416B (zh) | 一种固定化微生物细胞转化神经节苷脂的方法 | |
WO2020037853A1 (zh) | 一种促进微循环、提高人体机能的组合物及其制法 | |
CN110257325A (zh) | 一种基于芦荟提取物的体外培养自愈合细胞的方法 | |
CN115153021B (zh) | 羊栖菜提取物及其在降脂降糖产品中的应用 | |
CN110960553B (zh) | 丙二酸修饰的富勒烯c70在制备治疗非酒精性脂肪肝病药物中的应用 | |
CN112076139B (zh) | 一种黑麦发酵产物及其制备方法和应用 | |
CN115353981B (zh) | 一种粗毛纤孔菌的液体发酵培养方法及活性代谢产物 | |
CN117159561B (zh) | 一种具有抗肥胖功效的亚麻籽多糖发酵物及其制备方法与应用 | |
CN106978466A (zh) | 一种活性人参皂苷的制取方法 | |
CN108949733B (zh) | 一种纳豆激酶提取液及其应用 | |
NZ754367A (en) | Dietary fiber and preparation method thereof | |
NZ754367B2 (en) | Dietary fiber and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240627 Address after: 101, Building 11, Chengji Center, No. 47 Heping Road, Lixia District, Jinan City, Shandong Province, 250013 Patentee after: Jinan Longyan Jiuzhen Biotechnology Co.,Ltd. Country or region after: China Address before: Building 2-601, Building 15, No. 38 Luo'an Road, Tianqiao District, Jinan City, Shandong Province, 250000 Patentee before: Jinan Qixiantang Biotechnology Co.,Ltd. Country or region before: China |